Cargando…
Identification of tumor-educated platelet biomarkers of non-small-cell lung cancer
BACKGROUND: Lung cancer is a severe cancer with a high death rate. The 5-year survival rate for stage III lung cancer is much lower than stage I. Early detection and intervention of lung cancer patients can significantly increase their survival time. However, conventional lung cancer-screening metho...
Autores principales: | Sheng, Meiling, Dong, Zhaohui, Xie, Yanping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241732/ https://www.ncbi.nlm.nih.gov/pubmed/30532555 http://dx.doi.org/10.2147/OTT.S177384 |
Ejemplares similares
-
Tumor‐educated platelet SNORD55 as a potential biomarker for the early diagnosis of non‐small cell lung cancer
por: Dong, Xiaohan, et al.
Publicado: (2021) -
Tumor-educated platelet blood tests for Non-Small Cell Lung Cancer detection and management
por: Antunes-Ferreira, Mafalda, et al.
Publicado: (2023) -
Small Nuclear RNAs (U1, U2, U5) in Tumor-Educated Platelets Are Downregulated and Act as Promising Biomarkers in Lung Cancer
por: Dong, Xiaohan, et al.
Publicado: (2020) -
Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets
por: Best, Myron G., et al.
Publicado: (2017) -
Tumor‐educated leukocytes mRNA as a diagnostic biomarker for non‐small cell lung cancer
por: Niu, Limin, et al.
Publicado: (2021)